Christopher Crean

1.1k total citations
22 papers, 520 citations indexed

About

Christopher Crean is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Psychiatry and Mental health. According to data from OpenAlex, Christopher Crean has authored 22 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Pediatrics, Perinatology and Child Health and 7 papers in Psychiatry and Mental health. Recurrent topics in Christopher Crean's work include Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Ion channel regulation and function (5 papers). Christopher Crean is often cited by papers focused on Epilepsy research and treatment (6 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Ion channel regulation and function (5 papers). Christopher Crean collaborates with scholars based in United States, United Kingdom and Canada. Christopher Crean's co-authors include Debra Tompson, Yü Huang, Friedrich C. Luft, Rudolf Schubert, Johanna Schleifenbaum, Galyna Dubrovska, Maik Gollasch, Carolin Köhn, Torsten Gloe and José L. Boyer and has published in prestigious journals such as Nature Communications, Journal of Pharmacology and Experimental Therapeutics and American Journal of Ophthalmology.

In The Last Decade

Christopher Crean

21 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher Crean United States	11	177	158	129	100	78	22	520
Alma Barajas‐Espinosa Mexico	12	167 0.9×	59 0.4×	37 0.3×	21 0.2×	13 0.2×	27	465
Maria A. Rivelli United States	14	137 0.8×	74 0.5×	110 0.9×	21 0.2×	6 0.1×	27	490
Ho K. Lee South Korea	10	320 1.8×	47 0.3×	66 0.5×	18 0.2×	59 0.8×	12	708
Verena Prokosch Germany	18	307 1.7×	12 0.1×	49 0.4×	539 5.4×	12 0.2×	79	851
R. Kelly Hester United States	13	184 1.0×	127 0.8×	66 0.5×	52 0.5×	5 0.1×	31	429
William F. Holt United States	13	253 1.4×	82 0.5×	81 0.6×	244 2.4×	4 0.1×	25	570
Magdalena Lam Australia	12	143 0.8×	15 0.1×	107 0.8×	16 0.2×	7 0.1×	15	498
Marjatta Lappi Finland	13	215 1.2×	13 0.1×	73 0.6×	41 0.4×	48 0.6×	18	580
Shimako Abe Japan	12	139 0.8×	138 0.9×	47 0.4×	6 0.1×	12 0.2×	31	420
Tianpeng Zheng China	17	109 0.6×	66 0.4×	152 1.2×	5 0.1×	17 0.2×	42	634

Countries citing papers authored by Christopher Crean

Since Specialization

Citations

This map shows the geographic impact of Christopher Crean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Crean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Crean more than expected).

Fields of papers citing papers by Christopher Crean

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Crean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Crean. The network helps show where Christopher Crean may publish in the future.

Co-authorship network of co-authors of Christopher Crean

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Crean. A scholar is included among the top collaborators of Christopher Crean based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Crean. Christopher Crean is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Crean, Christopher, et al.. (2025). Comparison of Pharmacokinetics of Long-Acting Local Analgesics: CPL-01, a Novel Extended-Release Ropivacaine, Demonstrates Consistent and Predictable Exposure Compared with Liposomal Bupivacaine. Clinical Drug Investigation. 45(2). 51–58.

Crean, Christopher, et al.. (2024). Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits. Journal of Ocular Pharmacology and Therapeutics. 40(9). 588–595. 1 indexed citations

Lim, Jeremy J., et al.. (2023). 2520. A Phase 1b Study of the Safety, Pharmacokinetics, and Ex Vivo Tick Killing of the Lyme Prophylaxis Candidate TP-05. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Battiston, Kyle G., Hans Fischer, Fan Gu, et al.. (2021). Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery. Nature Communications. 12(1). 2875–2875. 32 indexed citations

Nau, Jeffrey, D.J. Wyatt, Hans Rollema, & Christopher Crean. (2021). A Phase I, Open-label, Randomized, 2-Way Crossover Study to Evaluate the Relative Bioavailability of Intranasal and Oral Varenicline. Clinical Therapeutics. 43(9). 1595–1607. 14 indexed citations

Fischer, Hans, et al.. (2020). Ocular pharmacokinetics, pharmacodynamics, and safety analysis of a novel dexamethasone intravitreal implant. Investigative Ophthalmology & Visual Science. 61(7). 28–28. 1 indexed citations

Tsujinaka, Hiroki, Jie Fu, Jikui Shen, et al.. (2020). Sustained treatment of retinal vascular diseases with self-aggregating sunitinib microparticles. Nature Communications. 11(1). 694–694. 62 indexed citations

Hoang, Bryan, et al.. (2018). An Injectable Depot Formulation of an Outflow Prodrug for Sustained Reduction of Intraocular Pressure. Investigative Ophthalmology & Visual Science. 59(9). 5710–5710. 1 indexed citations

Tompson, Debra, et al.. (2014). Lack of effect of ezogabine/retigabine on the pharmacokinetics of digoxin in healthy individuals: results from a drug–drug interaction study. Clinical Pharmacology Advances and Applications. 6. 149–149. 5 indexed citations

10.

Tompson, Debra, et al.. (2014). Effect of Hemodialysis on Pharmacokinetics of Ezogabine/Retigabine and its N-Acetyl Metabolite in Patients with End Stage Renal Disease. Current Clinical Pharmacology. 9(4). 319–325. 3 indexed citations

11.

Tompson, Debra & Christopher Crean. (2014). The Interaction Potential of Retigabine (Ezogabine) with Other Antiepileptic Drugs. Current Clinical Pharmacology. 9(2). 148–156. 10 indexed citations

12.

Tompson, Debra & Christopher Crean. (2013). Clinical Pharmacokinetics of Retigabine/Ezogabine. Current Clinical Pharmacology. 8(4). 319–331. 21 indexed citations

13.

Crean, Christopher & Debra Tompson. (2013). The Effects of Ethanol on the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Ezogabine (Retigabine). Clinical Therapeutics. 35(1). 87–93. 12 indexed citations

14.

Tompson, Debra, et al.. (2013). Efficacy and Tolerability Exposure–Response Relationship of Retigabine (Ezogabine) Immediate-Release Tablets in Patients With Partial-Onset Seizures. Clinical Therapeutics. 35(8). 1174–1185.e4. 9 indexed citations

15.

Large, Charles H., David M. Sokal, Astrid Nehlig, et al.. (2012). The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: Implications for clinical use. Epilepsia. 53(3). 425–436. 60 indexed citations

16.

Crean, Christopher, et al.. (2010). Pharmacokinetics of Azithromycin and Moxifloxacin in Human Conjunctiva and Aqueous Humor During and After the Approved Dosing Regimens. American Journal of Ophthalmology. 150(5). 744–751.e2. 1 indexed citations

17.

Schleifenbaum, Johanna, Carolin Köhn, Galyna Dubrovska, et al.. (2010). Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide. Journal of Hypertension. 28(9). 1875–1882. 155 indexed citations

18.

Akpek, Esen K., Jason L. Vittitow, K. Brubaker, et al.. (2009). Ocular Surface Distribution and Pharmacokinetics of a Novel Ophthalmic 1% Azithromycin Formulation. Journal of Ocular Pharmacology and Therapeutics. 25(5). 433–440. 57 indexed citations

19.

Roeloffs, Rosemarie, Alan D. Wickenden, Christopher Crean, et al.. (2008). In Vivo Profile of ICA-27243 [N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a Potent and Selective KCNQ2/Q3 (Kv7.2/Kv7.3) Activator in Rodent Anticonvulsant Models. Journal of Pharmacology and Experimental Therapeutics. 326(3). 818–828. 54 indexed citations

20.

Johnson, Fred L., José L. Boyer, Philip T. Leese, et al.. (2007). Rapid and reversible modulation of platelet function in man by a novel P2Y₁₂ADP-receptor antagonist, INS50589. Platelets. 18(5). 346–356. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact